MARCO MARCELLI to Carrier Proteins
This is a "connection" page, showing publications MARCO MARCELLI has written about Carrier Proteins.
Connection Strength
0.225
-
Monogene and polygene therapy for the treatment of experimental prostate cancers by use of apoptotic genes bax and bad driven by the prostate-specific promoter ARR(2)PB. Hum Gene Ther. 2002 Nov 20; 13(17):2051-64.
Score: 0.121
-
Altered growth and insulin-like growth factor-binding protein-3 production in PC3 prostate carcinoma cells stably transfected with a constitutively active androgen receptor complementary deoxyribonucleic acid. Endocrinology. 1995 Mar; 136(3):1040-8.
Score: 0.071
-
Overexpression of BCL-X(L) underlies the molecular basis for resistance to staurosporine-induced apoptosis in PC-3 cells. Cancer Res. 2001 Feb 15; 61(4):1699-706.
Score: 0.027
-
Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. Hum Mol Genet. 1999 May; 8(5):731-41.
Score: 0.006